We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Association Between Publication Characteristics and Treatment Effect Estimates: A Meta-epidemiologic Study.
Annals of Internal Medicine 2018 September 19
Background: Evidence about the effect on meta-analysis results of including unpublished trials or those published in languages other than English is unclear or discordant.
Purpose: To compare treatment effects between published and unpublished randomized controlled trials (RCTs) and between trials published in English and other languages using a meta-epidemiologic approach.
Data Sources: Cochrane reviews published between March 2011 and January 2017 and trial references cited in the reviews.
Study Selection: RCTs included in meta-analyses of 3 or more trials with a binary efficacy outcome.
Data Extraction: Trial characteristics were extracted by original review authors. A single reviewer assessed publication status and language, with quality assurance by another investigator.
Data Synthesis: Among 5659 RCTs included in 698 meta-analyses, 5303 (93.7%) were published in journal articles and 356 (6.3%) were unpublished. Of journal articles, 92.6% (4910 of 5303) were published in English and 7.4% (393 of 5303) in another language. Treatment effects were larger in published than unpublished trials (combined ratio of odds ratios [ROR] for 174 meta-analyses, 0.90 [95% CI, 0.82 to 0.98]; I2 = 19.3%; τ2 = 0.0492). Treatment effects were also larger for trials published in a language other than English than in English (combined ROR for 147 meta-analyses, 0.86 [CI, 0.78 to 0.95]; I2 = 0%; τ2 = 0.0000).
Limitation: Reliance on the primary reference cited by review authors as the record of interest.
Conclusion: In meta-analyses, treatment effects were larger in published than unpublished trials and, for published trials, in those published in a language other than English than in English.
Primary Funding Source: Cochrane France.
Purpose: To compare treatment effects between published and unpublished randomized controlled trials (RCTs) and between trials published in English and other languages using a meta-epidemiologic approach.
Data Sources: Cochrane reviews published between March 2011 and January 2017 and trial references cited in the reviews.
Study Selection: RCTs included in meta-analyses of 3 or more trials with a binary efficacy outcome.
Data Extraction: Trial characteristics were extracted by original review authors. A single reviewer assessed publication status and language, with quality assurance by another investigator.
Data Synthesis: Among 5659 RCTs included in 698 meta-analyses, 5303 (93.7%) were published in journal articles and 356 (6.3%) were unpublished. Of journal articles, 92.6% (4910 of 5303) were published in English and 7.4% (393 of 5303) in another language. Treatment effects were larger in published than unpublished trials (combined ratio of odds ratios [ROR] for 174 meta-analyses, 0.90 [95% CI, 0.82 to 0.98]; I2 = 19.3%; τ2 = 0.0492). Treatment effects were also larger for trials published in a language other than English than in English (combined ROR for 147 meta-analyses, 0.86 [CI, 0.78 to 0.95]; I2 = 0%; τ2 = 0.0000).
Limitation: Reliance on the primary reference cited by review authors as the record of interest.
Conclusion: In meta-analyses, treatment effects were larger in published than unpublished trials and, for published trials, in those published in a language other than English than in English.
Primary Funding Source: Cochrane France.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app